Muscle

Global Hormone Replacement Therapy Market 2022: A $25+ Billion Market by 2027 - Industry Trends, Growth, Impact of Inflation, Opportunities, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023

The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Global Hormone Replacement Therapy Market is expected to reach US$ 25.09 Billion by 2027 from US$ 18.04 Billion in 2022, growing with a CAGR of 6.82% during 2022-2027.
  • According to the UN, the global population will grow by 8.5 billion in 2030 and 9.7 billion in 2050.
  • Based on Type, hormone replacement therapy is categorized into Estrogen, Human Growth, Thyroid, Testosterone, and Progestogen.

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity

Retrieved on: 
Thursday, January 12, 2023

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, today announced that the BELIEVE Phase 2b study to assess the safety and efficacy of bimagrumab alone and in combination with semaglutide for the treatment of obesity has begun enrolling at sites in the U.S., Australia, and New Zealand.

Key Points: 
  • It is the only candidate in clinical development for the treatment of obesity that drives substantial fat loss while also increasing muscle mass.
  • "We are thrilled with the enthusiasm for the study and have already enrolled close to 20% of our targeted patients."
  • BELIEVE is a randomized, placebo-controlled, 48-week global Phase 2b study targeting enrollment of 450 non-diabetic patients with overweight or obesity who will receive placebo or bimagrumab, with or without semaglutide.
  • The study will assess the safety and efficacy of bimagrumab both as a monotherapy and when co-administered with semaglutide.

Le-Vel Introduces THRIVE ELITE: An Enhanced 3-Step System Designed for Weight Management

Retrieved on: 
Thursday, January 12, 2023

FRISCO, Texas, Jan. 12, 2023 /PRNewswire/ -- After 10 Years of dedicated research in the health & wellness industry, immense success from the THRIVE Experience launched in 2012, 10 million customers worldwide, 30 patents and counting, and almost $3 billion in lifetime sales, Le-Vel has done it again with a re-engineered formula specifically designed for maximum nutritional weight management possibilities.

Key Points: 
  • THRIVE ELITE is a reformulation and re-engineering of what is arguably the world's most successful nutritional system, the THRIVE Experience.
  • THRIVE ELITE was built upon the classic THRIVE Experience, but has been significantly enhanced to target weight management from a healthy, nutritional perspective.
  • The THRIVE ELITE Experience is based on a simple, 1-2-3 process, formulated to synergistically enhance weight management goals.
  • Le-Vel products include the THRIVE Experience and THRIVE ELITE Experience (consisting of the three core products, THRIVE Premium Lifestyle DFT, THRIVE Premium Lifestyle Capsules and THRIVE Premium Lifestyle Mix), and a CBD skincare system.

Los Angeles Stem Cell Therapy For Chronic Pain & Knee Injury Treatment Expanded

Retrieved on: 
Tuesday, January 24, 2023

Springs Rejuvenation (+1-404-780-5617) has expanded its stem cell treatment program for Los Angeles patients with knee and joint pain. The experienced team helps patients to improve their health and wellness or improve athletic performance.

Key Points: 
  • In addition to this, studies have shown that stem cell therapy can be an alternative option for treating autoimmune conditions and multiple sclerosis symptoms.
  • A representative at Springs Rejuvenation states: "During a stem cell therapy procedure at Springs, Dr. Pereyra will inject stem cells/exosomes either intravenously or into the injured joint.
  • According to a review published in the Journal of Orthopedic Translation, studies have shown that stem cell therapy may be effective in improving pain and function in patients with knee osteoarthritis.
  • In addition to the Los Angeles clinic, it offers treatment to patients in Atlanta, Austin, and South Florida.

Stirling CBD Discusses Impact of CBD on Busy Entrepreneurs

Retrieved on: 
Friday, January 13, 2023

But one tech professional, Luke Zarcone, is facing the stress of today's society with the aid of an unconventional ally — Stirling CBD cannabinoid-based products.

Key Points: 
  • But one tech professional, Luke Zarcone, is facing the stress of today's society with the aid of an unconventional ally — Stirling CBD cannabinoid-based products.
  • Before using CBD and other cannabinoid supplements, he used many other supplements, but they did not provide the results he sought.
  • After discovering the health benefits of CBD products, Luke immediately incorporated them into his busy lifestyle.
  • As the increase in CBD continues to rise, authentic CBD companies like Stirling CBD stay true to their commitment to offering the highest quality CBD products in the market.

The Fountain of Youth Med Spa Transforming Beauty through Botox

Retrieved on: 
Friday, January 13, 2023

The Fountain of Youth Med Spa in Greenwood Village, Colorado, near Denver is proud to serve the area as a medical spa offering botox .

Key Points: 
  • The Fountain of Youth Med Spa in Greenwood Village, Colorado, near Denver is proud to serve the area as a medical spa offering botox .
  • The Fountain of Youth Med Spa is proud to offer a full suite of Botox treatments for a wide range of needs.
  • For anyone still unsure as to whether Botox is the right choice, turn to the experts at Fountain of Youth, a Denver, Colorado-area medical spa offering Botox .
  • Easily find directions to The Fountain of Youth Med Spa and pay them a visit today!

Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform

Retrieved on: 
Thursday, January 12, 2023

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today the publication of a preclinical study highlighting new advances for its engineered exosome program. The data was published online in bioRxiv and explored the therapeutic potential of Capricor’s proprietary StealthX™ exosome platform, which generated two vaccine candidates (STX-S and STX-N), that independently, and in combination (STX-S+N) induced a strong immune response against two SARS-CoV-2 proteins, spike and nucleocapsid. Results showed that this multivalent, protein-based vaccine candidate has the potential to achieve potent, longer lasting immunization, broaden reactivity and improve T-cell response with only nanograms of protein without any adjuvant. The data from this study suggests that StealthX™ could deliver a more potent vaccine with broader immunity than is currently available, by combining the advantages of both mRNA and recombinant protein vaccines into a potentially superior, rapidly generated, low-dose vaccine.

Key Points: 
  • SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today the publication of a preclinical study highlighting new advances for its engineered exosome program.
  • More broadly, this data establishes StealthX™ as a vaccine platform with broad applications across infectious disease, as well as the prospect of combining multiple targets in one vaccine.
  • The study also investigated the combination of STX-S and STX-N, namely STX-S+N, in two independent animal models.
  • The results show efficacy of this multivalent protein-based vaccine for SARS-CoV-2 and suggests that other vaccines or therapeutics could be rapidly developed using the same StealthX™ platform.

Collagen Supplement Global Market Report 2022: Rising Awareness of Health Benefits Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023

The global collagen supplement market size reached US$ 2.06 Billion in 2021.

Key Points: 
  • The global collagen supplement market size reached US$ 2.06 Billion in 2021.
  • Besides this, the rising awareness among the masses about the benefits of collagen supplements to prevent collagen deficiency in the body is contributing to the growth of the market.
  • This, along with the growing utilization of collagen supplements in the food and beverage (F&B) industry, is offering a positive market outlook.
  • The publisher provides an analysis of the key trends in each sub-segment of the global collagen supplement market report, along with forecasts at the global, regional and country level from 2022-2027.

Synchron Announces Publication of Brain-Computer Interface Clinical Trial in JAMA Neurology

Retrieved on: 
Monday, January 9, 2023

Synchron , an implantable brain-computer interface (BCI) company, today announced the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe paralysis implanted with Synchron’s first-generation Stentrode™, a neuroprosthesis device.

Key Points: 
  • Synchron , an implantable brain-computer interface (BCI) company, today announced the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe paralysis implanted with Synchron’s first-generation Stentrode™, a neuroprosthesis device.
  • Three out of six participants have been enrolled in the COMMAND trial, two in New York City and one in Pittsburgh.
  • For healthcare providers, patients, or caregivers interested in learning more about our ongoing US clinical trial, email: [email protected] .
  • A BCI could restore motor capability by using the cortical motor signal to bypass impaired limbs and directly control a computer.

Dr. Roxana Barad is Pioneering Emface, a Needle-Free, Laser-Free Cosmetic Procedure Helping Patients Look Years Younger

Retrieved on: 
Tuesday, January 10, 2023

Unlike lasers, PDO threads, or micro-needling -- procedures that require numbing and recovery time -- Emface works non-invasively and painlessly. Radiofrequency stimulates collagen and elastin production and improves skin quality. Electric stimulation, delivered by three strategically placed electrodes, targets muscles that lift the brows and cheeks. For best results, Dr. Barad recommends having the 20- to 30- minute treatment sessions every week for a month.

Key Points: 
  • It combines radio frequency waves that heat the dermal skin layer with muscle stimulation to rejuvenate and lift the face.
  • Unlike lasers, PDO threads, or micro-needling -- procedures that require numbing and recovery time -- Emface works non-invasively and painlessly.
  • For best results, Dr. Barad recommends having the 20- to 30- minute treatment sessions every week for a month.
  • Those who can't attend, are still eligible for a free consultation and discounted Emface/Emsculpt treatments through Jan. 31.